Contact information
+44 (0)1865 857253
Research groups
Ruth Coleman
MSc
Head of Statistics & Modelling Group
Ruth is the Head of Statistics and Modelling Group, responsible for the management of the unit’s statistical output, maintaining transparency and presenting results in an impartial and objective manner.
In her time in the DTU she has gained extensive experience in the design, analysis and reporting of phase 2-4 trials with a focus on large scale cardiovascular outcome trials including TECOS, EXSCEL and ACE. Outside of trial work, the group use data from both randomized controlled trials and observational studies to evaluate diabetes-related complications and mortality, and produce validated prediction models to contribute to the improvement of outcomes in people with diabetes.
Her ongoing projects include the expansion of the UKPDS Risk Engine to include estimates of both cardiovascular and microvascular disease risk, and modelling life expectancy in type 2 diabetes.
She is currently a co-investigator on the UKPDS Legacy Study and the statistical lead for the ACE trial.
Recent publications
-
Glucocorticoid-induced hyperglycaemia in hospitalised adults: A matched cohort study (2013-2023).
Golubic R. et al, (2025), Diabetes Obes Metab
-
Risk factors for bone fractures in type 2 diabetes and the impact of once-weekly exenatide: Insights from an EXSCEL post-hoc analysis.
Maddaloni E. et al, (2025), Diabetes Res Clin Pract
-
The legacy effect of hyperglycaemia in type 2 diabetes - Authors' reply.
Adler AI. et al, (2025), Lancet, 405
-
Glucocorticoid treatment and new-onset hyperglycaemia and diabetes in people living with chronic obstructive pulmonary disease: A systematic review and meta-analysis.
Golubic R. et al, (2024), Diabet Med
-
Younger-onset compared with later-onset type 2 diabetes: an analysis of the UK Prospective Diabetes Study (UKPDS) with up to 30 years of follow-up (UKPDS 92).
Lin B. et al, (2024), Lancet Diabetes Endocrinol